Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carvacrol is a monoterpenoid phenol and a natural compound found in the essential oils of various plants, notably oregano. It is recognized for its pungent aroma and diverse biological activities. Carvacrol exhibits strong antimicrobial effects against numerous bacteria and fungi by disrupting cytoplasmic membrane integrity, leading to ATP depletion in microbial cells. Its mechanism of action includes acting as an agonist of the Transient receptor potential cation channel subfamily A member 1 (TRPA1) receptor, contributing to anti-inflammatory effects by reducing pro-inflammatory cytokines and oxidative stress markers. Carvacrol also demonstrates antioxidant properties by inducing enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR), and catalase (CAT). Additional reported activities include antitumor, antimutagenic, anti-obesity, hepatoprotective, cardioprotective, neuroprotective effects via modulation of neurotransmitter pathways (serotonergic, dopaminergic, GABAergic), inhibition of prostaglandin production and Nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carvacrol.